Brief: Neurotrope Bioscience Announces Agreement With Worldwide Clinical Trials

NextTrip

30/07/2020 14:10

July 30 (Reuters) - Neurotrope Inc  NTRP.O :
    * NEUROTROPE BIOSCIENCE ANNOUNCES AGREEMENT WITH WORLDWIDE
CLINICAL TRIALS, TO CONDUCT ONGOING PHASE 2 STUDY OF
BRYOSTATIN-1, PARTIALLY FUNDED BY NIH, FOR ALZHEIMER'S DISEASE
    * NEUROTROPE - PHASE 2 BRYOSTATIN-1 CLINICAL STUDY IS BEING
CONDUCTED IN COLLABORATION WITH NIH UNDER $2.7 MILLION GRANT TO
CO
    * NEUROTROPE - EXPECTS TO DOSE FIRST PATIENT IN LATE Q3 OR
EARLY
Q4 FOR PHASE 2 BRYOSTATIN-1 STUDY

Source text for Eikon:  ID:nPn98J5Pha 
Further company coverage:  NTRP.O 

 ((Reuters.Briefs@thomsonreuters.com;))